JAK2 and myeloproliferative neoplasm: In addition, vascular endothelial cells carrying the JAK2 V617F mutation have been detected in patients with MPN, and expression of the mutation in vascular endothelial cells altered their function and response to shear stress to a pro-adhesive and pro-inflammatory phenotype promoting thrombosis and platelet adhesion in the blood vessels [75].